Journal of Traditional Chinese Medicine >
Efficacy of Qingre Huashi decoction (清热化湿方) on infection of Helicobacter pylori: inhibiting adhesion, antioxidant, and anti-inflammation
Received date: 2021-12-12
Accepted date: 2022-02-22
Online published: 2022-09-22
Supported by
Research on Mechanisms of Jinghua Weikang Capsule Interving HP Infection and Related Inflammation through Adhersin-ROS/ MAPKR-NFκB Pathway(81973615);Effect and Mechanism of Jinghua Weikang Capsule Inhibiting the Adhesion Effect of Helicobacter pylori(7172220)
OBJECTIVE: To investigate the phytochemical profile of Qingre Huashi decoction (清热化湿方, QHD) and evaluate the mechanisms rationalizing the use of QHD against Helicobacter pylori (H. pylori)-associated gastritis.
METHODS: QHD is composed of 11 herbs, which was prepared by a fixed Pharmacy and concentrated into clear paste. High-performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry (HPLC-QTOF/MS) was used to detect the phytochemical profile of QHD. The toxicity of QHD against H. pylori and human gastric epithelial cells was evaluated by the toxicology test and cell counting kit-8 assay. The adhesion model was constructed by incubating H. pylori and gastric mucosal epithelial cells for 2 h. The urease assay was used to examine the anti-adhesion effects of QHD, and gene expression of adhesins was evaluated by quantitative polymerase chain reaction. The antioxidant activity was assessed by DCFH-DA labeling. To evaluate the anti-inflammatory effect, the levels of pro-inflammatory cytokines in the culture supernatant were detected by enzyme-linked immunosorbent assay.
RESULTS: HPLC-QTOF/MS profiling indicated the presence of primary compounds 1-20 in QHD. Drug concentration was determined as 1, 2, and 5 mg/mL by the toxic concentration of QHD against H. pylori and human gastric epithelial cells. QHD prevented H. pylori adhesion to the human gastric epithelial cells and reduced levels of reactive oxygen species. QHD also reduced the level of interleukin-8 and other pro-inflammatory cytokines that were upregulated by H. pylori infection.
CONCLUSION: QHD could inhibit H. pylori adhesion, and exert antioxidant and anti-inflammatory effects in vitro.
Qiuyue HUANG , Hui YE , Zongming SHI , Xiaofen JIA , Miaomiao LIN , Yingming CHU , Jing YU , Xuezhi ZHANG . Efficacy of Qingre Huashi decoction (清热化湿方) on infection of Helicobacter pylori: inhibiting adhesion, antioxidant, and anti-inflammation[J]. Journal of Traditional Chinese Medicine, 2022 , 42(6) : 915 -921 . DOI: 10.19852/j.cnki.jtcm.20220922.001
| [1] | Cover TL, Blaser MJ. Helicobacter pylori in health and disease. Gastroenterology 2009; 136: 1863-73. |
| [2] | Sugano K, Tack J, Kuipers EJ. Kyoto global consensus report on Helicobacter pylori gastritis. Gut 2015; 64: 1353-67. |
| [3] | Choi IJ, Kook MC, Kim YI. Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N Engl J Med 2018; 378: 1085-95. |
| [4] | Hu Y, Zhu Y, Lu NH. Primary antibiotic resistance of Helicobacter pylori in China. Dig Dis Sci 2017; 62: 1146-54. |
| [5] | Savoldi A, Carrara E, Graham DY, Conti M, Tacconelli E. Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and Meta-analysis in World Health Organization regions. Gastroenterology 2018; 155: 1372-82.e17. |
| [6] | Takeuchi H, Trang VT, Morimoto N, Nishida Y, Matsumura Y, Sugiura T. Natural products and food components with anti-Helicobacter pylori activities. World J Gastroenterol 2014; 20: 8971-8. |
| [7] | Goderska K, Agudo Pena S, Alarcon T. Helicobacter pylori treatment: antibiotics or probiotics. Appl Microbiol Biotechnol 2018; 102: 1-7. |
| [8] | Hu FL, Zhang SS. National consensus on integrated treatment of Helicobacter pylori related "disease-syndrome". Zhong Guo Zhong Xi Yi Jie He Xiao Hua Za Zhi 2018; 26: 715-23. |
| [9] | Abadi ATB. Strategies used by helicobacter pylori to establish persistent infection. World J Gastroenterol 2017; 23: 2870-82. |
| [10] | Keilberg D, Ottemann KM. How Helicobacter pylori senses, targets and interacts with the gastric epithelium. Environ Microbiol 2016; 18: 791-806. |
| [11] | Oleastro M, Ménard A. The role of Helicobacter pylori outer membrane proteins in adherence and pathogenesis. Biology (Basel) 2013; 2: 1110-34. |
| [12] | Ofek I, Hasty DL, Sharon N. Anti-adhesion therapy of bacterial diseases: prospects and problems. FEMS Immunol Med Microbiol 2003; 38: 181-91. |
| [13] | Ohno T, Vallström A, Rugge M, et al. Effects of blood group antigen-binding adhesin expression during Helicobacter pylori infection of Mongolian gerbils. J Infect Dis 2011; 203: 726-35. |
| [14] | Ishijima N, Suzuki M, Ashida H, et al. BabA-mediated adherence is a potentiator of the Helicobacter pylori type Ⅳ secretion system activity. J Biol Chem 2011; 286: 25256-64. |
| [15] | Unemo M, Aspholm-Hurtig M, Ilver D, et al. The sialic acid binding SabA adhesin of Helicobacter pylori is essential for nonopsonic activation of human neutrophils. J Biol Chem 2005; 280: 15390-7. |
| [16] | Butcher LD, den Hartog G, Ernst PB, Crowe SE. Oxidative stress resulting from Helicobacter pylori infection contributes to gastric carcinogenesis. Cell Mol Gastroenterol Hepatol 2017; 3: 316-22. |
| [17] | Sun YM, Huang J, Chen Q, et al. Exploring the inflammatory microenvironment of Hp-related CAG from the theory of dampness-heat of spleen and stomach. Xian Dai Zhong Yi Lin Chuang 2021; 13: 64-6. |
| [18] | Huang QY, Ye H, Shi ZM, Yang SS, Jia XF, Zhang XZ. Understanding the inflammatory process of Helicobacter pylori adhesion based on damp-heat theory. Shi Jie Zhong Xi Yi Jie He Za Zhi 2021; 16: 185-8. |
| [19] | Yang SS, Ye H, Huang QY, Deng X, Xiao HX, Zhang XZ. A randomized controlled clinical study of Qingre Huashi decoction combined with triple therapy in treating Helicobacter pylori infection of damp-heat type of spleen and stomach. Shi Jie Zhong Xi Yi Jie He Za Zhi 2020; 15: 1734-8. |
| [20] | Yu J, Ye H, Li N, Li J, Chen Y, Zhang XZ. Anti-bacterial and anti-inflammatory effects of Qingre Huashi formula on Helicobacter pylori-infected mice. Zhong Cheng Yao 2017; 39: 7-14. |
| [21] | Vale FF, Oleastro M. Overview of the phytomedicine approaches against Helicobacter pylori. World J Gastroenterol 2014; 20: 5594-609. |
| [22] | Salehi B, Sharopov F, Martorell M, et al. Phytochemicals in Helicobacter pylori infections: what are we doing now? Int J Mol Sci 2018; 19: 2361. |
| [23] | Chen Y, Liu QY, Ye H, et al. Multi-center study of Chinese medicine syndrome types and syndrome factors evolvement law of Helicobacter pylori related gastropathy. Xian Dai Zhong Yi Lin Chuang 2015; 22: 12-6. |
| [24] | Ye H, Shi ZM, Chen Y, Yu J, Zhang XZ. Innovative perspectives of integrated chinese medicine on H. pylori. Chin J Integr Med 2018; 24: 873-80. |
| [25] | Alarcón T, Domingo D, Prieto N, López-Brea M. Bacteriostatic and bactericidal activity of ranitidine bismuth citrate in Helico-bacter pylori clinical isolates. Rev Esp Quimioter. 1999; 12: 64-8. |
| [26] | Ilver D, Arnqvist A, Ogren J, et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 1998; 279: 373-7. |
| [27] | Magalhães A, Marcos-Pinto R, Nairn AV, et al. Helicobacter pylori chronic infection and mucosal inflammation switches the human gastric glycosylation pathways. Biochim Biophys Acta 2015; 1852: 1928-39. |
| [28] | Fu HW. Helicobacter pylori neutrophil-activating protein: from molecular pathogenesis to clinical applications. World journal of gastroenterology 2014; 20: 5294-301. |
| [29] | Messing J, Niehues M, Shevtsova A, Borén T, Hensel A. Antiadhesive properties of arabinogalactan protein from ribes nigrum seeds against bacterial adhesion of Helicobacter pylori. Molecules 2014; 19: 3696-717. |
| [30] | de Klerk N, Maudsdotter L, Gebreegziabher H, et al. Lactobacilli reduce Helicobacter pylori attachment to host gastric epithelial cells by inhibiting adhesion gene expression. Infection and immunity 2016; 84: 1526-35. |
| [31] | Bagheri V, Memar B, Momtazi AA, Sahebkar A, Gholamin M, Abbaszadegan MR. Cytokine networks and their association with Helicobacter pylori infection in gastric carcinoma. J Cell Physiol 2018; 233: 2791-803. |
| [32] | Handa O, Naito Y, Yoshikawa T. Helicobacter pylori: a ROS-inducing bacterial species in the stomach. Inflamm Res 2010; 59: 997-1003. |
| [33] | Kuete V, Efferth T. Cameroonian medicinal plants: pharmacology and derived natural products. Front Pharmacol 2010; 1: 123. |
| [34] | Lee JH, Shim JS, Lee JS, Kim MK, Chung MS, Kim KH. Pectin-like acidic polysaccharide from Panax ginseng with selective antiadhesive activity against pathogenic bacteria. Carbohydr Res 2006; 341: 1154-63. |
| [35] | Thöle C, Brandt S, Ahmed N, Hensel A. Acetylated rhamnogalacturonans from immature fruits of abelmoschus esculentus inhibit the adhesion of Helicobacter pylori to human gastric cells by interaction with outer membrane proteins. Molecules 2015; 20: 16770-87. |
| [36] | Wittschier N, Faller G, Hensel A. Aqueous extracts and polysaccharides from liquorice roots (Glycyrrhiza glabra L.) inhibit adhesion of Helicobacter pylori to human gastric mucosa. J Ethnopharmacol 2009; 125: 218-23. |
| [37] | Li Y, Li X, Tan Z. An overview of Traditional Chinese Medicine therapy for Helicobacter pylori-related gastritis. Helicobacter 2021: e12799. |
| [38] | Chang CH, Wu JB, Yang JS, et al. The suppressive effects of geniposide and genipin on Helicobacter pylori infections in vitro and in vivo. J Food Sci 2017; 82: 3021-8. |
| [39] | Luo H, Wu H, Yu X, et al. A review of the phytochemistry and pharmacological activities of Magnoliae officinalis cortex. J Ethnopharmacol 2019; 236: 412-42. |
| [40] | Tan L, Li C, Chen H, et al. Epiberberine, a natural protoberberine alkaloid, inhibits urease of Helicobacter pylori and jack bean: susceptibility and mechanism. Eur J Pharm Sci 2017; 110: 77-86. |
/
| 〈 |
|
〉 |